Purespring
@Purespringtx
Followers
81
Following
2
Statuses
182
Let's transform the treatment of kidney diseases. We tweet about our cool science, our #Purespringers and making a difference to patients.
London, UK
Joined September 2020
Purespring has been featured in the inaugural edition of @thetimes 100 Tech 2025 ‘#Biotech Ones to Watch,’ highlighting the strength of our team and our leading AAV #GeneTherapy platform for the treatment of #KidneyDisease. For more: #SundayTimes100
0
0
1
Thrilled to see that Sandra Currie, CEO at @Kidney_Research, has been named an Officer of the British Empire (OBE) in recognition of Services to People Affected by #KidneyDisease. Congratulations, Sandra! To learn more: #Research #Innovation
0
0
5
#HappyHolidays from the team at Purespring Therapeutics! 2024 has been an incredibly exciting year for us, and we look forward to advancing our novel #GeneTherapy platform to transform the lives of people affected by #KidneyDisease.
0
0
2
Our team will be on the ground in San Francisco from 13-16 January for #JPM25. If you are also attending and would like to learn more about our #GeneTherapy approach for the treatment of #KidneyDisease, please contact r.muccio@purespringtx.com to connect. #JPM2025 #Biotech
0
0
2
Purespring’s CSO, Alice Brown, recently presented at @TheCIPA’s annual Life Sciences Conference, providing senior leaders in the IP field with a comprehensive overview of our scientific and corporate journey. #Biotech #GeneTherapy #KidneyDisease
0
0
1
Last week, Richard Truran, VP Development, delivered a seminar to @UCL's MSc Cell & Gene Therapy students, sharing insights into our first-in-class #GeneTherapy platform and highlights from his career in #biotech. Thank you to UCL for hosting! #KidneyDisease #People
0
0
1
Purespring recently attended the @Kidney_Research Andy Cole Fund Gala, an annual fundraising event to raise vital funds for #research into #KidneyDisease. We’re grateful to be able to attend events such as these, and thank you to Sandra Currie and KRUK for a great evening.
0
0
4
Next week, Alice Brown, CSO, will be participating in a panel discussion alongside other #LifeSciences experts at the @BIA_UK's Annual #bioProcessUK Conference. The panel, "Question Time - Celebrating Sector Investment," will take place from 10:00-11:00GMT on 20 November.
0
0
2
Members of the Purespring management team attending the @Jefferies Healthcare Conference in London next week. If you’re also participating and would like to discuss our novel AAV #GeneTherapy approach for treating chronic #KidneyDisease, please get in touch. #JefferiesHealthcare
0
0
0
Our VP of CMC, Amanda Weiss, and VP of Development, Richard Truran, recently attended @CRiverLabs’ Cell and #GeneTherapy Summit Europe, where they enjoyed hearing from a diverse selection of subject matter experts from across the space. #KidneyDisease #Biotech #Innovation
0
0
1
On Saturday, Ambra Cappelletto, Principal Scientist, presented new preclinical data at the @ASNKidney #KidneyWeek 2024, underpinning the potential of our novel #GeneTherapy programme, PS-002, for IgAN treatment. For more: #KidneyDisease #Biotech #People
0
0
1
Yesterday, Julian Hanak, CEO, joined Amy Brown from #BiotechTV to speak about our recent £80 million ($105 million) Series B #fundraising and #ClinicalDevelopment plans for our lead programme, PS-002, for the treatment of IgAN. #Biotech #KidneyDisease #GeneTherapy
𝐅𝐫𝐨𝐦 𝐋𝐨𝐧𝐝𝐨𝐧: @Purespringtx raised a $105M series B earlier this month to advance AAV gene therapies for kidney diseases, including both monogenic and non-monogenic diseases. Full video:
0
0
2
Our team is at the @ESGCT Annual Congress this week, held in Rome from 22-25 October. If you are also attending and would like to learn more about novel #GeneTherapy platform for the treatment of chronic #KidneyDisease, please reach out to connect. #ESGCT2024 #GeneTherapy
0
0
3
Next week, Purespring will be on the ground in San Diego for @ASNKidney’s #KidneyWeek 2024. Be sure to stop by Ambra Cappelletto’s presentation to learn more about the potential of our #GeneTherapy approach for the treatment of IgAN. For more:
1
0
2
Our Senior Director of Clinical Ops, Charlotte Smerdon, recently attended the #EvolutionSummit, where she was part of an interactive panel discussing patient engagement in clinical trials. Excited to share insights and advance patient-centric research practices! #ClinicalResearch
0
0
2
We are proud to announce that we have raised £80M ($105M) in a Series B #financing, which will be used to advance our #GeneTherapy approach towards #ClinicalTrials. To learn more: #Biotech #Innovation
0
2
4
On 21 September, Professor Moin Saleem will present on #podocyte dysfunction and #GeneTherapy as part of the Travere Rare Kidney Disease SciNet Summit’s ‘Future of FSGS & MCD Diagnosis and Treatment: What’s on the Horizon’ session. Join him at 14:45CDT to learn more. #Biotech
0
0
1
Professor Moin Saleem, our Co-Founder and Chief Scientific Advisor, has joined the Board of Trustees at @Kidney_Research, the UK’s leading charity dedicated to finding new ways to prevent, treat and manage #KidneyDisease. #research #innovation
0
3
10
This week, Ambra Cappelletto will be in Gothenburg, Sweden for #ISCTEurope2024 to participate in the ‘Improving AAV Vector Designs: New Concepts for #GeneTherapy Translation.’ If you are also attending, be sure to stop by room F2 from 8:00-9:00CEST on 6 September to learn more.
0
0
0
Purespring recently joined over 1300 other participants for @Kidney_Research’s London Bridges walk. The event raised £110,000 to progress cutting edge #research into the causes, prevention and treatment of #KidneyDisease. Thank you to KRUK for organising such a great day out!
1
0
2